Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021134

Expand all

NITROSTAT (NITROGLYCERIN)
0.3MG Marketing Status: Prescription

Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROSTAT
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.3MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021134
Product Number: 001
Approval Date: May 1, 2000
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

NITROSTAT (NITROGLYCERIN)
0.4MG Marketing Status: Prescription

Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROSTAT
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.4MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021134
Product Number: 002
Approval Date: May 1, 2000
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

NITROSTAT (NITROGLYCERIN)
0.6MG Marketing Status: Prescription

Active Ingredient: NITROGLYCERIN
Proprietary Name: NITROSTAT
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: 0.6MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021134
Product Number: 003
Approval Date: May 1, 2000
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English